Lower rates of intraocular inflammation with aflibercept 8 mg delivered via pre-filled syringe versus vial

Katja Hatz; Laura Hoffmann

doi:10.3205/26doc027

June 17, 2026Open Access

Lower rates of intraocular inflammation with aflibercept 8 mg delivered via pre-filled syringe versus vial

View Full Paper

Ask AI

Bookmark

Share

Key Points

This research aims to compare the incidence of sterile intraocular inflammation following injections of aflibercept administered via different delivery methods.
Retrospective multicenter review of electronic medical records
Focus on the use of pre-filled syringes versus vials for aflibercept injections
Assessment of outcomes over a 1.5-year period
Lower rates of intraocular inflammation observed with pre-filled syringes compared to vials.

Implication

Retrospective multicenter study reveals reduced intraocular inflammation with pre-filled syringe injections of aflibercept.

Abstract

Purpose: To report 1.5-year real-world outcomes on the incidence of sterile intraocular inflammation (IOI) following intravitreal aflibercept 8 mg injections, with emphasis on differences between vial and pre-filled syringe (PFS) use. Methods: This retrospective multicenter study reviewed electronic [for full text, please go to the a.m. URL]

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Hatz et al. (2026) studied this question.

synapsesocial.com/papers/6a34dd1d65a5b0777af2cf74 https://doi.org/10.3205/26doc027

View Full Paper

Ask AI

Bookmark

Share

Lower rates of intraocular inflammation with aflibercept 8 mg delivered via pre-filled syringe versus vial

Key Points

Implication

Abstract

Discussion

Cite This Study

Lower rates of intraocular inflammation with aflibercept 8 mg delivered via pre-filled syringe versus vial

Key Points

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading